Nouvelle déclaration d'incident
No de la demande: 2009-2700
Numéro de référence du titulaire d'homologation: Prosar 1-18684431
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: UNITED STATES
État: ARKANSAS
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2596-150
Nom du produit: UltraGuard Plus Flea/Tick Drops Plus for Dogs/Puppies 4-15 lbs
Liquide
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Inconnu
Professionnel de la santé
Dog / Chien
Miniature Poodle
1
Femme
3
6
lbs
Cutanée
>24 hrs <=3 days / >24 h <=3 jours
Unknown / Inconnu
Système
Persisted until death
Oui
Oui
1
Day(s) / Jour(s)
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
1-18684431: A reporter (veterinarian) called on 06/02/2009 to report the exposure of a dog to a topical flea and tick product containing the active ingredients Phenothrin and Methoprene. According to the reporter, the product was applied to the dog on 05/30/2009. On 05/31/2009, the dog was stumbling, unable to walk, and shaking. The dog was brought to the veterinarian on 06/01/2009 where it was hyperthermic and had tremors. The dog was bathed in Dawn dish soap and its signs resolved within one hour of bathing. The dog was discharged that same day with oral Robaxin (methocarbamol). A heartworm and a fecal exam were negative. The dog was brought back to the veterinarian on 06/02/2009 because the dog was having tremors and was recumbent. At the time of the report, the veterinarian had given the dog subcutaneous fluids and its temperature was slightly elevated. The reporter was advised that the signs described are not expected with routine use of the product. A recommendation was made to re-bathe the dog in Dawn dish soap to remove any product residue. The reporter was advised that the remainder of care is directed as symptoms. A recommendation was made to continue methocarbamol treatment, and dosage guidelines were provided. It was also recommended that the dog be monitored for 48-72 hours. On follow up on 06/03/2009, the reporter stated that the dog had been on IV fluids, methocarbamol, and Benadryl. The dog died earlier that day. The reporter was encouraged to consider necropsy to try to determine the cause of death. Information regarding necropsy protocol and the company's reimbursement policy was provided. No further information was obtained.
Mort